The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Teriparatide Injection Market Research Report 2025
Synopsis
The global Teriparatide Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Teriparatide Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Teriparatide Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Teriparatide Injection include Eli Lilly and Company, Alvogen, Pfenex Inc., Shenzhen Salubris Pharmaceuticals Co., Ltd. and Shanghai United Cell Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Teriparatide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teriparatide Injection.
Report Scope
The Teriparatide Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Teriparatide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Teriparatide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Alvogen
Pfenex Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shanghai United Cell Biotechnology Co., Ltd.
Segment by Type
2.5 ML
3.0 ML
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Teriparatide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Teriparatide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Teriparatide Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Teriparatide Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Teriparatide Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Teriparatide Injection include Eli Lilly and Company, Alvogen, Pfenex Inc., Shenzhen Salubris Pharmaceuticals Co., Ltd. and Shanghai United Cell Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Teriparatide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teriparatide Injection.
Report Scope
The Teriparatide Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Teriparatide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Teriparatide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Alvogen
Pfenex Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shanghai United Cell Biotechnology Co., Ltd.
Segment by Type
2.5 ML
3.0 ML
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Teriparatide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Teriparatide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Teriparatide Injection Market Overview
1.1 Product Overview and Scope of Teriparatide Injection
1.2 Teriparatide Injection Segment by Type
1.2.1 Global Teriparatide Injection Market Value Comparison by Type (2024-2030)
1.2.2 2.5 ML
1.2.3 3.0 ML
1.3 Teriparatide Injection Segment by Application
1.3.1 Global Teriparatide Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Teriparatide Injection Market Size Estimates and Forecasts
1.4.1 Global Teriparatide Injection Revenue 2019-2030
1.4.2 Global Teriparatide Injection Sales 2019-2030
1.4.3 Global Teriparatide Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Teriparatide Injection Market Competition by Manufacturers
2.1 Global Teriparatide Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Teriparatide Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Teriparatide Injection Average Price by Manufacturers (2019-2024)
2.4 Global Teriparatide Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Teriparatide Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Teriparatide Injection, Product Type & Application
2.7 Teriparatide Injection Market Competitive Situation and Trends
2.7.1 Teriparatide Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Teriparatide Injection Players Market Share by Revenue
2.7.3 Global Teriparatide Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Teriparatide Injection Retrospective Market Scenario by Region
3.1 Global Teriparatide Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Teriparatide Injection Global Teriparatide Injection Sales by Region: 2019-2030
3.2.1 Global Teriparatide Injection Sales by Region: 2019-2024
3.2.2 Global Teriparatide Injection Sales by Region: 2025-2030
3.3 Global Teriparatide Injection Global Teriparatide Injection Revenue by Region: 2019-2030
3.3.1 Global Teriparatide Injection Revenue by Region: 2019-2024
3.3.2 Global Teriparatide Injection Revenue by Region: 2025-2030
3.4 North America Teriparatide Injection Market Facts & Figures by Country
3.4.1 North America Teriparatide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Teriparatide Injection Sales by Country (2019-2030)
3.4.3 North America Teriparatide Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Teriparatide Injection Market Facts & Figures by Country
3.5.1 Europe Teriparatide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Teriparatide Injection Sales by Country (2019-2030)
3.5.3 Europe Teriparatide Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Teriparatide Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Teriparatide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Teriparatide Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Teriparatide Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Teriparatide Injection Market Facts & Figures by Country
3.7.1 Latin America Teriparatide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Teriparatide Injection Sales by Country (2019-2030)
3.7.3 Latin America Teriparatide Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Teriparatide Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Teriparatide Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Teriparatide Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Teriparatide Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Teriparatide Injection Sales by Type (2019-2030)
4.1.1 Global Teriparatide Injection Sales by Type (2019-2024)
4.1.2 Global Teriparatide Injection Sales by Type (2025-2030)
4.1.3 Global Teriparatide Injection Sales Market Share by Type (2019-2030)
4.2 Global Teriparatide Injection Revenue by Type (2019-2030)
4.2.1 Global Teriparatide Injection Revenue by Type (2019-2024)
4.2.2 Global Teriparatide Injection Revenue by Type (2025-2030)
4.2.3 Global Teriparatide Injection Revenue Market Share by Type (2019-2030)
4.3 Global Teriparatide Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Teriparatide Injection Sales by Application (2019-2030)
5.1.1 Global Teriparatide Injection Sales by Application (2019-2024)
5.1.2 Global Teriparatide Injection Sales by Application (2025-2030)
5.1.3 Global Teriparatide Injection Sales Market Share by Application (2019-2030)
5.2 Global Teriparatide Injection Revenue by Application (2019-2030)
5.2.1 Global Teriparatide Injection Revenue by Application (2019-2024)
5.2.2 Global Teriparatide Injection Revenue by Application (2025-2030)
5.2.3 Global Teriparatide Injection Revenue Market Share by Application (2019-2030)
5.3 Global Teriparatide Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Teriparatide Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Company Teriparatide Injection Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Alvogen
6.2.1 Alvogen Corporation Information
6.2.2 Alvogen Description and Business Overview
6.2.3 Alvogen Teriparatide Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alvogen Teriparatide Injection Product Portfolio
6.2.5 Alvogen Recent Developments/Updates
6.3 Pfenex Inc.
6.3.1 Pfenex Inc. Corporation Information
6.3.2 Pfenex Inc. Description and Business Overview
6.3.3 Pfenex Inc. Teriparatide Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfenex Inc. Teriparatide Injection Product Portfolio
6.3.5 Pfenex Inc. Recent Developments/Updates
6.4 Shenzhen Salubris Pharmaceuticals Co., Ltd.
6.4.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Corporation Information
6.4.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Description and Business Overview
6.4.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Portfolio
6.4.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.5 Shanghai United Cell Biotechnology Co., Ltd.
6.5.1 Shanghai United Cell Biotechnology Co., Ltd. Corporation Information
6.5.2 Shanghai United Cell Biotechnology Co., Ltd. Description and Business Overview
6.5.3 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Portfolio
6.5.5 Shanghai United Cell Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Teriparatide Injection Industry Chain Analysis
7.2 Teriparatide Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Teriparatide Injection Production Mode & Process
7.4 Teriparatide Injection Sales and Marketing
7.4.1 Teriparatide Injection Sales Channels
7.4.2 Teriparatide Injection Distributors
7.5 Teriparatide Injection Customers
8 Teriparatide Injection Market Dynamics
8.1 Teriparatide Injection Industry Trends
8.2 Teriparatide Injection Market Drivers
8.3 Teriparatide Injection Market Challenges
8.4 Teriparatide Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Teriparatide Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Teriparatide Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Teriparatide Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Teriparatide Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Teriparatide Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Teriparatide Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Teriparatide Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Teriparatide Injection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Teriparatide Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Teriparatide Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Teriparatide Injection, Product Type & Application
Table 12. Global Key Manufacturers of Teriparatide Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Teriparatide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teriparatide Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Teriparatide Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Teriparatide Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Teriparatide Injection Sales Market Share by Region (2019-2024)
Table 19. Global Teriparatide Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Teriparatide Injection Sales Market Share by Region (2025-2030)
Table 21. Global Teriparatide Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Teriparatide Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Teriparatide Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Teriparatide Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Teriparatide Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Teriparatide Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Teriparatide Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Teriparatide Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Teriparatide Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Teriparatide Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Teriparatide Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Teriparatide Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Teriparatide Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Teriparatide Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Teriparatide Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Teriparatide Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Teriparatide Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Teriparatide Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Teriparatide Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Teriparatide Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Teriparatide Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Teriparatide Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Teriparatide Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Teriparatide Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Teriparatide Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Teriparatide Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Teriparatide Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Teriparatide Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Teriparatide Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Teriparatide Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Teriparatide Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Teriparatide Injection Sales Market Share by Type (2019-2024)
Table 53. Global Teriparatide Injection Sales Market Share by Type (2025-2030)
Table 54. Global Teriparatide Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Teriparatide Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Teriparatide Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Teriparatide Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Teriparatide Injection Price (USD/Unit) by Type (2019-2024)
Table 59. Global Teriparatide Injection Price (USD/Unit) by Type (2025-2030)
Table 60. Global Teriparatide Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Teriparatide Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Teriparatide Injection Sales Market Share by Application (2019-2024)
Table 63. Global Teriparatide Injection Sales Market Share by Application (2025-2030)
Table 64. Global Teriparatide Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Teriparatide Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Teriparatide Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Teriparatide Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Teriparatide Injection Price (USD/Unit) by Application (2019-2024)
Table 69. Global Teriparatide Injection Price (USD/Unit) by Application (2025-2030)
Table 70. Eli Lilly and Company Corporation Information
Table 71. Eli Lilly and Company Description and Business Overview
Table 72. Eli Lilly and Company Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Eli Lilly and Company Teriparatide Injection Product
Table 74. Eli Lilly and Company Recent Developments/Updates
Table 75. Alvogen Corporation Information
Table 76. Alvogen Description and Business Overview
Table 77. Alvogen Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Alvogen Teriparatide Injection Product
Table 79. Alvogen Recent Developments/Updates
Table 80. Pfenex Inc. Corporation Information
Table 81. Pfenex Inc. Description and Business Overview
Table 82. Pfenex Inc. Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Pfenex Inc. Teriparatide Injection Product
Table 84. Pfenex Inc. Recent Developments/Updates
Table 85. Shenzhen Salubris Pharmaceuticals Co., Ltd. Corporation Information
Table 86. Shenzhen Salubris Pharmaceuticals Co., Ltd. Description and Business Overview
Table 87. Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product
Table 89. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 90. Shanghai United Cell Biotechnology Co., Ltd. Corporation Information
Table 91. Shanghai United Cell Biotechnology Co., Ltd. Description and Business Overview
Table 92. Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product
Table 94. Shanghai United Cell Biotechnology Co., Ltd. Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Teriparatide Injection Distributors List
Table 98. Teriparatide Injection Customers List
Table 99. Teriparatide Injection Market Trends
Table 100. Teriparatide Injection Market Drivers
Table 101. Teriparatide Injection Market Challenges
Table 102. Teriparatide Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Teriparatide Injection
Figure 2. Global Teriparatide Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Teriparatide Injection Market Share by Type in 2023 & 2030
Figure 4. 2.5 ML Product Picture
Figure 5. 3.0 ML Product Picture
Figure 6. Global Teriparatide Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Teriparatide Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Teriparatide Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Teriparatide Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Teriparatide Injection Sales (2019-2030) & (K Units)
Figure 14. Global Teriparatide Injection Average Price (USD/Unit) & (2019-2030)
Figure 15. Teriparatide Injection Report Years Considered
Figure 16. Teriparatide Injection Sales Share by Manufacturers in 2023
Figure 17. Global Teriparatide Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Teriparatide Injection Players: Market Share by Revenue in 2023
Figure 19. Teriparatide Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Teriparatide Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Teriparatide Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Teriparatide Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Teriparatide Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Teriparatide Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Teriparatide Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Teriparatide Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Teriparatide Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Teriparatide Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Teriparatide Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Teriparatide Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Teriparatide Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Teriparatide Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Teriparatide Injection by Type (2019-2030)
Figure 55. Global Teriparatide Injection Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Teriparatide Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Teriparatide Injection by Application (2019-2030)
Figure 58. Global Teriparatide Injection Price (USD/Unit) by Application (2019-2030)
Figure 59. Teriparatide Injection Value Chain
Figure 60. Teriparatide Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
